Skip to main content
SpringerLink
Log in

Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review

  • Review Article
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

T1a and T1b glottic squamous cell carcinoma (SCC) are often analyzed together by authors who investigate the oncologic outcomes achieved after different therapeutic options. Nevertheless, T1b definitely represents a more advanced tumor stage compared to T1a glottic SCC. The objective of this review was first to analyze the overall success rates in the treatment of patients affected by T1b glottic SCC. Moreover, a subgroup analysis was planned to specifically compare the outcomes obtained with radiotherapy (RT), transoral laser microsurgery (TLM) and open partial laryngectomies (OPL). An electronic library search of the relevant English literature was performed. Potentially eligible articles were reviewed. Qualified articles were selected and evaluated. Fifty-two studies comprising 2360 patients were included. The overall rate of disease-free survival (DFS) was 85% (95% CI 83–87). The overall rate of overall survival was 85% (95% CI 80–88) while the rate of disease-specific survival (DSS) was found to be 96% (95% CI 90–98). Statistical data concerning outcomes for each therapeutic modality showed an higher DFS rate for subjects treated with RT and OPL, respectively, 87% (95% CI 0.85–0.89) and 83% (95% CI 0.78–0.89), when compared to those who underwent TLM 77% (95% CI 0.69–0.83). In conclusion, our results showed a high level of overall DSS (96%) for patients affected by T1b glottic SCC. Regarding the specific therapeutic options, our subgroup analysis showed as patients treated with TLM present a higher rate of oncological recurrence in comparison to those who underwent RT or OPL. Nevertheless, on the basis of our data it was also noted that no significant differences subsist in terms of survival rates among the three different treatments. Moreover, the absence of a comparative analysis useful to confirm these conclusions must be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rettig EM, D’Souza G (2015) Epidemiology of head and neck cancer. Surg Oncol Clin N Am 24(3):379–396

    Article  PubMed  Google Scholar 

  2. Abdurehim Y, Hua Z, Yasin Y, Xukurhan A, Imam I, Yuqin F (2012) Transoral laser surgery versus radiotherapy: systematic review and meta-analysis for treatment options of T1a glottic cancer. Head Neck 34(1):23–33

    Article  PubMed  Google Scholar 

  3. Dinapoli N, Parrilla C, Galli J, Autorino R, Miccichè F, Bussu F, Balducci M, D’Alatri L, Marchese R, Rigante M, Di Lella G, Liberati L, Almadori G, Paludetti G, Valentini V (2010) Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population. Strahlenther Onkol 186(11):607–613

    Article  PubMed  Google Scholar 

  4. Marcotullio D, de Vincentiis M, Iannella G, Bigelli C, Magliulo G (2014) Surgical treatment of T1b glottic tumor, 10-years follow-up. Eur Rev Med Pharmacol Sci 18(8):1212–1217

    CAS  PubMed  Google Scholar 

  5. Remmelts AJ, Hoebers FJ, Klop WM, Balm AJ, Hamming-Vrieze O, van den Brekel MW (2013) Evaluation of laser surgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice. Eur Arch Otorhinolaryngol 270(7):2079–2087

    Article  CAS  PubMed  Google Scholar 

  6. Szyfter W, Leszczyńska M, Wierzbicka M, Kopeć T, Bartochowska A (2013) Value of open horizontal glottectomy in the treatment for T1b glottic cancer with anterior commissure involvement. Head Neck 35(12):1738–1744

    Article  PubMed  Google Scholar 

  7. Rödel RM, Steiner W, Müller RM, Kron M, Matthias C (2009) Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure. Head Neck 31(5):583–592

    Article  PubMed  Google Scholar 

  8. Kirchner JA, Carter D (1987) Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol (Stockh) 103:503–513

    CAS  Google Scholar 

  9. Bagatella F, Bignardi L (1981) Morphological study of the laryngeal anterior commissure with regard to the spread of cancer. Acta Otolaryngol (Stockh) 92:167–171

    Article  CAS  Google Scholar 

  10. Lee HS, Chun BG, Kim SW, Kim ST, Oh JH, Hong JC, Lee KD (2013) Transoral laser microsurgery for early glottic cancer as one-stage single-modality therapy. Laryngoscope 123(11):2670–2674

    Article  PubMed  Google Scholar 

  11. Higgins J, Thompson S, Deeks J, Altman D (2002) Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 7:51–61

    Article  PubMed  Google Scholar 

  12. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Warner L, Chudasama J, Kelly CG, Loughran S, McKenzie K, Wight R, Dey P (2014) Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 12:CD002027

    Google Scholar 

  14. Feng Y, Wang B, Wen S (2011) Laser surgery versus radiotherapy for T1–T2N0 glottic cancer: a meta-analysis. ORL J Otorhinolaryngol Relat Spec 73(6):336–342

    Article  PubMed  Google Scholar 

  15. Hartl DM, Ferlito A, Brasnu DF, Langendijk JA, Rinaldo A, Silver CE, Wolf GT (2011) Evidence-based review of treatment options for patients with glottic cancer. Head Neck 33(11):1638–1648

    Article  PubMed  Google Scholar 

  16. Higgins KM (2011) What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Laryngoscope 121(1):116–134

    Article  PubMed  Google Scholar 

  17. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB (2004) Management of T1–T2 glottic carcinomas. Cancer 100(9):1786–1792

    Article  PubMed  Google Scholar 

  18. Yoo J, Lacchetti C, Hammond JA, Gilbert RW, Head and Neck Cancer Disease Site Group (2014) Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: a systematic review. Head Neck 36(12):1807–1819

    Article  PubMed  Google Scholar 

  19. O’Hara J, Markey A, Homer JJ (2013) Transoral laser surgery versus radiotherapy for tumour stage 1a or 1b glottic squamous cell carcinoma: systematic review of local control outcomes. J Laryngol Otol 127(8):732–738

    Article  PubMed  Google Scholar 

  20. Chone CT, Yonehara E, Martins JE, Altemani A, Crespo AN (2007) Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg 133(9):882–887

    Article  PubMed  Google Scholar 

  21. Hakeem AH, Tubachi J, Pradhan SA (2013) Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with trans-oral CO2 laser microsurgery. Laryngoscope 123(8):1912–1917

    Article  PubMed  Google Scholar 

  22. Sachse F, Stoll W, Rudack C (2009) Evaluation of treatment results with regard to initial anterior commissure involvement in early glottic carcinoma treated by external partial surgery or transoral laser microresection. Head Neck 31(4):531–537

    Article  PubMed  Google Scholar 

  23. Tamaki Y, Hieda Y, Yoshida R, Yoshizako T, Fuchiwaki T, Aoi N, Sekihara K, Kitajima K, Kawauchi H, Kitagaki H, Sasaki R, Inomata T (2015) Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer. Nagoya J Med Sci 77(4):585–594

    PubMed  PubMed Central  Google Scholar 

  24. Hoffmann C, Cornu N, Hans S, Sadoughi B, Badoual C, Brasnu D (2016) Early glottis cancer involving the anterior commissure treated by transoral laser cordectomy. Laryngoscope 126(8):1817–1822

    Article  PubMed  Google Scholar 

  25. Ermiş E, Teo M, Dyker KE, Fosker C, Sen M, Prestwich RJ (2015) Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55 Gy in 20 fractions. Radiat Oncol 23(10):203

    Article  Google Scholar 

  26. Harada A, Sasaki R, Miyawaki D, Yoshida K, Nishimura H, Ejima Y, Kitajima K, Saito M, Otsuki N, Nibu K (2015) Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery. Jpn J Clin Oncol 45(3):248–255

    Article  PubMed  Google Scholar 

  27. Lei WB, Jiang AY, Chai LP, Zhu XL, Wang ZF, Wen YH, Su ZZ, Wen WP (2013) Middle frontal horizontal partial laryngectomy (MFHPL): a treatment for stage T1b squamous cell carcinoma of the glottic larynx involving anterior vocal commissure. PLoS ONE 8(1):e52723

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Khan MK, Koyfman SA, Hunter GK, Reddy CA, Saxton JP (2012) Definitive radiotherapy for early (T1–T2) glottic squamous cell carcinoma: a 20 year Cleveland clinic experience. Radiat Oncol 19(7):193

    Article  Google Scholar 

  29. Hirasawa N, Itoh Y, Naganawa S, Ishihara S, Suzuki K, Koyama K, Murao T, Asano A, Nomoto Y, Horikawa Y, Sasaoka M, Obata Y (2012) Multi-institutional analysis of early glottic cancer from 2000 to 2005. Radiat Oncol 1(7):122

    Article  Google Scholar 

  30. Tong CC, Au KH, Ngan RK, Cheung FY, Chow SM, Fu YT, Au JS, Law SC (2012) Definitive radiotherapy for early stage glottic cancer by 6 MV photons. Head Neck Oncol 4:23

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gultekin M, Ozyar E, Cengiz M, Ozyigit G, Hayran M, Hosal S, Akyol F (2012) High daily fraction dose external radiotherapy for T1 glottic carcinoma: treatment results and prognostic factors. Head Neck 34(7):1009–1014

    Article  PubMed  Google Scholar 

  32. Manzo R, Ravo V, Murino P, Morra A, Panetti G, Laudati A, Prisco A, Panelli G, Muto P (2010) Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy. Tumori 96(4):577–581

    PubMed  Google Scholar 

  33. Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM (2010) T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 78(2):461–466

    Article  PubMed  Google Scholar 

  34. Jones DA, Mendenhall CM, Kirwan J, Morris CG, Donnan A, Holwerda S, Kraus ST, Mann CJ, Grant JR, Donnan B, Mendenhall WM (2010) Radiation therapy for management of t1–t2 glottic cancer at a private practice. Am J Clin Oncol 33(6):587–590

    Article  PubMed  Google Scholar 

  35. Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S (2008) Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Laryngoscope 118(8):1417–1421

    Article  CAS  PubMed  Google Scholar 

  36. Motta G, Esposito E, Motta S, Tartaro G, Testa D (2005) CO2 laser surgery in the treatment of glottic cancer. Head Neck 27(8):733

    Article  PubMed  Google Scholar 

  37. Thariat J, Bruchon Y, Bonnetain F, Barillot I, Truc G, Peignaux K, Horiot JC, Maingon P (2004) Conservative treatment of early glottic carcinomas with exclusive radiotherapy. Cancer Radiother 8(5):288–296

    Article  CAS  PubMed  Google Scholar 

  38. Steiner W, Ambrosch P, Rödel RM, Kron M (2004) Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope 114(8):1485–1491

    Article  PubMed  Google Scholar 

  39. Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M (2004) Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension. Strahlenther Onkol 180(2):84–90

    Article  PubMed  Google Scholar 

  40. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW (2001) T1–T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19(20):4029–4036

    Article  CAS  PubMed  Google Scholar 

  41. Pignataro L, Capaccio P, Neglia CB, Ottaviani A (2000) Clinical experience with the treatment of T1b glottic cancer by means of horizontal glottectomy. Eur Arch Otorhinolaryngol 257(4):216–218

    Article  CAS  PubMed  Google Scholar 

  42. Spector JG, Sessions DG, Chao KS, Haughey BH, Hanson JM, Simpson JR, Perez CA (1999) Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck 21(8):707–717

    Article  CAS  PubMed  Google Scholar 

  43. Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M (1997) Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys 38(5):1001–1006

    Article  CAS  PubMed  Google Scholar 

  44. Sjögren EV, Wiggenraad RG, Le Cessie S, Snijder S, Pomp J, Baatenburg de Jong RJ (2009) Outcome of radiotherapy in T1 glottic carcinoma: a population-based study. Eur Arch Otorhinolaryngol 266(5):735–744

    Article  PubMed  Google Scholar 

  45. Reddy SP, Hong RL, Nagda S, Emami B (2007) Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 69(5):1389–1394

    Article  PubMed  Google Scholar 

  46. Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E, De Stefani A, Buglione M, Biti G (2005) Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 63(5):1378–1386

    Article  PubMed  Google Scholar 

  47. Warde P, O’Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, Waldron J, Cummings BJ (1998) T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 41(2):347–353

    Article  CAS  PubMed  Google Scholar 

  48. Nishimura Y, Nagata Y, Okajima K, Mitsumori M, Hiraoka M, Masunaga S, Ono K, Shoji K, Kojima H (1996) Radiation therapy for T1, 2 glottic carcinoma: impact of overall treatment time on local control. Radiother Oncol 40(3):225–232

    Article  CAS  PubMed  Google Scholar 

  49. Inoue T, Matayoshi Y, Inoue T, Ikeda H, Teshima T, Murayama S (1993) Prognostic factors in telecobalt therapy for early supraglottic carcinoma. Cancer 72(1):57–61

    Article  CAS  PubMed  Google Scholar 

  50. Cheah NL, Lupton S, Marshall A, Hartley A, Glaholm J (2009) Outcome of T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham experience. Clin Oncol (R Coll Radiol) 21(6):494–501

    Article  CAS  Google Scholar 

  51. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ (2003) Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital experience. Radiother Oncol 68(2):105–111

    Article  PubMed  Google Scholar 

  52. Jin J, Liao Z, Gao L, Huang X, Xu G (2002) Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of Medical Sciences. Int J Radiat Oncol Biol Phys 54(2):471–478

    Article  PubMed  Google Scholar 

  53. Lee JH, Machtay M, McKenna MG, Weinstein GS, Markiewicz DA, Krisch RE, Kligerman MM (2001) Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord. Am J Otolaryngol 22(1):43–54 (review)

    Article  CAS  PubMed  Google Scholar 

  54. Mendelsohn AH, Kiagiadaki D, Lawson G, Remacle M (2015) CO2 laser cordectomy for glottic squamous cell carcinoma involving the anterior commissure: voice and oncologic outcomes. Eur Arch Otorhinolaryngol 272(2):413–418

    Article  PubMed  Google Scholar 

  55. Moon SH, Cho KH, Chung EJ, Lee CG, Lee KC, Chai GY, Kang KM, Lee JY, Chung WK, Park WY, Kim JH (2014) A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1–2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study. Radiother Oncol 110(1):98–103

    Article  PubMed  Google Scholar 

  56. Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M (2006) Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 64(1):77–82

    Article  PubMed  Google Scholar 

  57. Franchin G, Minatel E, Gobitti C, Talamini R, Sartor G, Caruso G, Grando G, Politi D, Gigante M, Toffoli G, Trovò MG, Barzan L (1998) Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis. Int J Radiat Oncol Biol Phys 40(3):541–548

    Article  CAS  PubMed  Google Scholar 

  58. Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA, Reddy SP (2000) P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 46(1):21–26

    Article  CAS  PubMed  Google Scholar 

  59. Foote RL, Buskirk SJ, Grado GL, Bonner JA (1997) Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer? Head Neck 19(8):692–700

    Article  CAS  PubMed  Google Scholar 

  60. Motta G, Esposito E, Cassiano B, Motta S (1997) T1–T2–T3 glottic tumors: fifteen years experience with CO2 laser. Acta Otolaryngol Suppl 527:155–159

    Article  CAS  PubMed  Google Scholar 

  61. Rucci L, Gallo O, Fini-Storchi O (1991) Glottic cancer involving anterior commissure: surgery vs radiotherapy. Head Neck 13(5):403–410

    Article  CAS  PubMed  Google Scholar 

  62. Chatani M, Matayoshi Y, Masaki N (1993) Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma. Strahlenther Onkol 169(2):102–106

    CAS  PubMed  Google Scholar 

  63. Chatani M, Matayoski Y, Masaki N, Teshima T, To I (1996) Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field. Strahlenther Onkol. 172(3):169–172 (erratum in: Strahlenther Onkol 1996;172(9):524)

    CAS  PubMed  Google Scholar 

  64. Dedivitis RA, Guimarães AV, Guirado CR (2005) Outcome after partial frontolateral laryngectomy. Int Surg 90(2):113–118

    PubMed  Google Scholar 

  65. Krawczyk J, Svoboda V, Foster L (1991) The influence of some factors on local control of early glottic cancer. Clin Oncol (R Coll Radiol) 3(6):330–334

    Article  CAS  Google Scholar 

  66. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR (1988) T1–T2 vocal cord carcinoma: a basis for comparing the results of radiotherapy and surgery. Head Neck Surg. 10(6):373–377

    Article  CAS  PubMed  Google Scholar 

  67. Nozaki M, Furuta M, Murakami Y, Izawa Y, Iwasaki N, Takahashi H, Watanabe K (2000) Radiation therapy for T1 glottic cancer: involvement of the anterior commissure. Anticancer Res. 20(2B):1121–1124

    CAS  PubMed  Google Scholar 

  68. Hirasawa N, Itoh Y, Ishihara S, Kubota S, Itoh J, Fujimoto Y, Nakashima T, Naganawa S (2010) Radiotherapy with or without chemotherapy for patients with T1–T2 glottic carcinoma: retrospective analysis. Head Neck Oncol 2:20

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ENT Unit, Department of Clinical and Molecular Sciences, Ospedali Riuniti of Ancona, Polytechnic University of Marche, Via Conca 71, 60020, Ancona, Italy

    Federico Maria Gioacchini & Massimo Re

  2. Department of Otorhinolaryngology, San Raffaele Scientific Institute, Milan, Italy

    Michele Tulli, Stefano Bondi & Mario Bussi

  3. Department of Diagnostic Medicine, Clinical and Public Health University Hospital of Modena, Modena, Italy

    Shaniko Kaleci

Authors
  1. Federico Maria Gioacchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michele Tulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shaniko Kaleci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stefano Bondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mario Bussi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Massimo Re
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All of the authors have read and approved the manuscript.

Corresponding author

Correspondence to Federico Maria Gioacchini.

Ethics declarations

Conflict of interest

No author has received research grants.

Human and animal rights statement

No animals were involved. No humans were involved.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Financial disclosure

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gioacchini, F.M., Tulli, M., Kaleci, S. et al. Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review. Eur Arch Otorhinolaryngol 274, 4091–4102 (2017). https://doi.org/10.1007/s00405-017-4736-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-017-4736-z

Keywords

Search

Navigation